Microencapsulation of anti-tuberculosis drugs using sporopollenin

In this thesis, we explore the benefits of microencapsulating isoniazid and pyrazinamide within sporopollenin exine capsules derived from Lycopodium clavatum. Sporopollenin is a natural biopolymer, which is extracted from the outer shell of pollen grains. These hollow microcapsules can encapsulate a...

Full description

Bibliographic Details
Main Author: Mhlana, Kanyisile
Format: Others
Language:English
Published: Nelson Mandela University 2017
Subjects:
Online Access:http://hdl.handle.net/10948/13912
id ndltd-netd.ac.za-oai-union.ndltd.org-nmmu-vital-27357
record_format oai_dc
spelling ndltd-netd.ac.za-oai-union.ndltd.org-nmmu-vital-273572018-01-30T03:57:46ZMicroencapsulation of anti-tuberculosis drugs using sporopolleninMhlana, KanyisileMycobacterium tuberculosis -- South Africa -- PreventionMicroencapsulationPlant sporesIn this thesis, we explore the benefits of microencapsulating isoniazid and pyrazinamide within sporopollenin exine capsules derived from Lycopodium clavatum. Sporopollenin is a natural biopolymer, which is extracted from the outer shell of pollen grains. These hollow microcapsules can encapsulate and release drug actives in a controlled manner and possess many other advantages such as homogeneity in morphology and size, resilience to both strong acids and bases, they have antioxidant properties as well as UV protection to protect the material inside the microcapsule. Compared to artificial microcapsules, sporopollenin’s muco-adhesion to intestinal tissues contributes greatly to the extended contact of the sporopollenin with the intestines leading to an increased efficiency of delivery of drugs. The hollow microcapsules can be easily filled with a solution of the active or active in a liquid form by simply mixing both together. The drug actives are released in the human body depending on pH factors. Active release can otherwise have controlled by adding a coating on the shell, or co-encapsulation with the active inside the shell so that high drug concentrations are delivered to the site of infection. Encapsulation of the drug active will possibly improve therapeutic abilities of the drugs; simplify the treatment of TB-HIV coinfections by eliminating troublesome drug-drug interactions and drastically reduce or eliminates side effects. The SECs were loaded using a passive filling method. The drug active (0.1 g) was dissolved in a solvent and mixed with the SECs (0.1 g) for 10 minutes. After mixing for 10 minutes, the solvent was removed by a rotary evaporator and dried to a constant mass. The surface of the sporopollenin exines were analysed on a FTIR to observe if there are any drug deposits on the surface of the SECs. The loading efficiency and drug release percentage was determined by using calibrations curves and analysed on a UV-vis spectrophotometer. Further work has been proposed in which to characterize the SECs further and producing coated tablets from loaded SECs.Nelson Mandela UniversityFaculty of Science2017ThesisMastersMScxiii, 92 leavespdfhttp://hdl.handle.net/10948/13912vital:27357EnglishNelson Mandela University
collection NDLTD
language English
format Others
sources NDLTD
topic Mycobacterium tuberculosis -- South Africa -- Prevention
Microencapsulation
Plant spores
spellingShingle Mycobacterium tuberculosis -- South Africa -- Prevention
Microencapsulation
Plant spores
Mhlana, Kanyisile
Microencapsulation of anti-tuberculosis drugs using sporopollenin
description In this thesis, we explore the benefits of microencapsulating isoniazid and pyrazinamide within sporopollenin exine capsules derived from Lycopodium clavatum. Sporopollenin is a natural biopolymer, which is extracted from the outer shell of pollen grains. These hollow microcapsules can encapsulate and release drug actives in a controlled manner and possess many other advantages such as homogeneity in morphology and size, resilience to both strong acids and bases, they have antioxidant properties as well as UV protection to protect the material inside the microcapsule. Compared to artificial microcapsules, sporopollenin’s muco-adhesion to intestinal tissues contributes greatly to the extended contact of the sporopollenin with the intestines leading to an increased efficiency of delivery of drugs. The hollow microcapsules can be easily filled with a solution of the active or active in a liquid form by simply mixing both together. The drug actives are released in the human body depending on pH factors. Active release can otherwise have controlled by adding a coating on the shell, or co-encapsulation with the active inside the shell so that high drug concentrations are delivered to the site of infection. Encapsulation of the drug active will possibly improve therapeutic abilities of the drugs; simplify the treatment of TB-HIV coinfections by eliminating troublesome drug-drug interactions and drastically reduce or eliminates side effects. The SECs were loaded using a passive filling method. The drug active (0.1 g) was dissolved in a solvent and mixed with the SECs (0.1 g) for 10 minutes. After mixing for 10 minutes, the solvent was removed by a rotary evaporator and dried to a constant mass. The surface of the sporopollenin exines were analysed on a FTIR to observe if there are any drug deposits on the surface of the SECs. The loading efficiency and drug release percentage was determined by using calibrations curves and analysed on a UV-vis spectrophotometer. Further work has been proposed in which to characterize the SECs further and producing coated tablets from loaded SECs.
author Mhlana, Kanyisile
author_facet Mhlana, Kanyisile
author_sort Mhlana, Kanyisile
title Microencapsulation of anti-tuberculosis drugs using sporopollenin
title_short Microencapsulation of anti-tuberculosis drugs using sporopollenin
title_full Microencapsulation of anti-tuberculosis drugs using sporopollenin
title_fullStr Microencapsulation of anti-tuberculosis drugs using sporopollenin
title_full_unstemmed Microencapsulation of anti-tuberculosis drugs using sporopollenin
title_sort microencapsulation of anti-tuberculosis drugs using sporopollenin
publisher Nelson Mandela University
publishDate 2017
url http://hdl.handle.net/10948/13912
work_keys_str_mv AT mhlanakanyisile microencapsulationofantituberculosisdrugsusingsporopollenin
_version_ 1718612073984819200